Stereotactic radiosurgery: a "targeted" therapy for cancer.
- Author:
Ming ZENG
1
;
Liang-Fu HAN
Author Information
- Publication Type:Journal Article
- MeSH: Clinical Trials, Phase III as Topic; Humans; Lung Neoplasms; surgery; Neoplasms; surgery; Radiosurgery; Radiotherapy Dosage; Survival Rate
- From:Chinese Journal of Cancer 2012;31(10):471-475
- CountryChina
- Language:English
- Abstract: The developments of medicine always follow innovations in science and technology. In the past decade, such innovations have made cancer-related targeted therapies possible. In general, the term "targeted therapy" has been used in reference to cellular and molecular level oriented therapies. However, improvements in the delivery and planning of traditional radiation therapy have also provided cancer patients more options for "targeted" treatment, notably stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). In this review, the progress and controversies of SRS and SBRT are discussed to show the role of stereotactic radiation therapy in the ever evolving multidisciplinary care of cancer patients.
